| |
| |
|
| Insider
Information: |
Feener Edward P. |
| Relationship: |
|
| City: |
Salisbury, Wiltshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
62,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$749,613 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,157 |
|
|
| Total
Value |
$749,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 172.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-02-20 |
62,157 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-20 |
4 |
AS |
$14.04 |
$397,929 |
D/D |
(28,288) |
62,157 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,788 |
90,445 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-14 |
4 |
S |
$15.01 |
$422,827 |
D/D |
(28,171) |
71,657 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
99,828 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-11 |
4 |
AS |
$13.03 |
$295,514 |
D/D |
(22,679) |
39,828 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-09 |
4 |
AS |
$13.00 |
$1,300 |
D/D |
(100) |
62,507 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2024-01-08 |
4 |
AS |
$13.01 |
$224,000 |
D/D |
(17,221) |
62,607 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-11-20 |
4 |
S |
$8.23 |
$40,801 |
D/D |
(4,958) |
79,828 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,497 |
84,786 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-08-18 |
4 |
S |
$10.73 |
$53,386 |
D/D |
(4,976) |
73,289 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,494 |
78,265 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-05-18 |
4 |
S |
$10.14 |
$18,118 |
D/D |
(1,786) |
66,771 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,205 |
68,557 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-02-17 |
4 |
S |
$7.66 |
$17,066 |
D/D |
(2,228) |
64,352 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,204 |
66,580 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2022-11-18 |
4 |
S |
$5.44 |
$2,883 |
D/D |
(530) |
62,376 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2022-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,774 |
62,906 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2022-08-17 |
4 |
S |
$14.96 |
$7,960 |
D/D |
(532) |
61,132 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2022-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,773 |
61,664 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2022-01-07 |
4 |
OE |
$7.07 |
$434,832 |
D/D |
57,657 |
59,891 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-11-01 |
4 |
AS |
$18.07 |
$108,424 |
D/D |
(6,000) |
2,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-08-02 |
4 |
AS |
$20.52 |
$123,134 |
D/D |
(6,000) |
8,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-06-02 |
4 |
AS |
$26.33 |
$216,696 |
D/D |
(8,200) |
14,234 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-06-01 |
4 |
AS |
$26.81 |
$691,665 |
D/D |
(25,800) |
22,434 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2021-05-03 |
4 |
OE |
$10.21 |
$61,260 |
D/D |
6,000 |
60,234 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
